Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YH001 |
Trade Name | |
Synonyms | YH 001|YH-001 |
Drug Descriptions |
YH001 is a humanized anti-CTLA4 antibody that may block immunosuppression in tumor microenvironment and enhance antitumor immune response (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2577-2577). |
DrugClasses | CTLA4 Antibody 31 |
CAS Registry Number | NA |
NCIT ID | C176873 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Doxorubicin + Envafolimab + YH001 | Doxorubicin Envafolimab YH001 | 0 | 1 |
Envafolimab + YH001 | Envafolimab YH001 | 0 | 1 |
Pembrolizumab + YH001 + YH003 | Pembrolizumab YH001 YH003 | 0 | 1 |
Toripalimab-tpzi + YH001 | Toripalimab-tpzi YH001 | 0 | 2 |
YH001 | YH001 | 0 | 0 |
YH001 + YH002 | YH001 YH002 | 0 | 1 |